Literature DB >> 19883363

Osteoclasts have multiple roles in bone in addition to bone resorption.

Brendan F Boyce1, Zhenqiang Yao, Lianping Xing.   

Abstract

Osteoclasts are the cells that degrade bone to initiate normal bone remodeling and mediate bone loss in pathologic conditions by increasing their resorptive activity. They are derived from precursors in the myeloid/ monocyte lineage that circulate in the blood after their formation in the bone marrow. These osteoclast precursors (OCPs) are attracted to sites on bone surfaces destined for resorption and fuse with one another to form the multinucleated cells that resorb calcified matrixes under the influence of osteoblastic cells in bone marrow. Recent studies have identified functions for OCPs and osteoclasts in and around bone other than bone resorption. For example, they regulate the differentiation of osteoblast precursors and the movement of hematopoietic stem cells from the bone marrow to the bloodstream; they participate in immune responses, and secrete cytokines that can affect their own functions and those of other cells in inflammatory and neoplastic processes affecting bone. Here, we review these findings, which define new roles for osteoclasts and OCPs in the growing field of osteoimmunology and in common pathologic conditions in which bone resorption is increased.

Entities:  

Mesh:

Year:  2009        PMID: 19883363      PMCID: PMC2856465          DOI: 10.1615/critreveukargeneexpr.v19.i3.10

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  53 in total

1.  Regulation of cell polarity and protrusion formation by targeting RhoA for degradation.

Authors:  Hong-Rui Wang; Yue Zhang; Barish Ozdamar; Abiodun A Ogunjimi; Evguenia Alexandrova; Gerald H Thomsen; Jeffrey L Wrana
Journal:  Science       Date:  2003-12-05       Impact factor: 47.728

Review 2.  Stem cell mobilization.

Authors:  Michele H Cottler-Fox; Tsvee Lapidot; Isabelle Petit; Orit Kollet; John F DiPersio; Dan Link; Steven Devine
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2003

3.  Effects of high dose IV pamidronate on disease activity and bone metabolism in patients with active RA: a randomized, double-blind, placebo-controlled trial.

Authors:  Mariette C Lodder; Philomine A Van Pelt; Willem F Lems; Piet J Kostense; Cees H W Koks; Ben A C Dijkmans
Journal:  J Rheumatol       Date:  2003-09       Impact factor: 4.666

4.  Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease.

Authors:  Heikki Valleala; Leena Laasonen; Marja-Kaisa Koivula; Jami Mandelin; Claes Friman; Juha Risteli; Yrjö T Konttinen
Journal:  J Rheumatol       Date:  2003-03       Impact factor: 4.666

5.  Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells.

Authors:  Fumiko Kanamaru; Hideyuki Iwai; Tohru Ikeda; Atsuo Nakajima; Isao Ishikawa; Miyuki Azuma
Journal:  Immunol Lett       Date:  2004-07-15       Impact factor: 3.685

6.  The TRAF6 RING finger domain mediates physical interaction with Ubc13.

Authors:  Jill Wooff; Landon Pastushok; Michelle Hanna; Yu Fu; Wei Xiao
Journal:  FEBS Lett       Date:  2004-05-21       Impact factor: 4.124

7.  Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice.

Authors:  Ping Li; Edward M Schwarz; Regis J O'Keefe; Lin Ma; R John Looney; Christopher T Ritchlin; Brendan F Boyce; Lianping Xing
Journal:  Arthritis Rheum       Date:  2004-01

8.  Osteoblastic cells regulate the haematopoietic stem cell niche.

Authors:  L M Calvi; G B Adams; K W Weibrecht; J M Weber; D P Olson; M C Knight; R P Martin; E Schipani; P Divieti; F R Bringhurst; L A Milner; H M Kronenberg; D T Scadden
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

9.  The origins of osteoclasts.

Authors:  Mark C Horowitz; Joseph A Lorenzo
Journal:  Curr Opin Rheumatol       Date:  2004-07       Impact factor: 5.006

10.  Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types.

Authors:  M A Horton; E F Rimmer; D Lewis; J A Pringle; K Fuller; T J Chambers
Journal:  J Pathol       Date:  1984-12       Impact factor: 7.996

View more
  39 in total

Review 1.  Aging and bone.

Authors:  A L Boskey; R Coleman
Journal:  J Dent Res       Date:  2010-10-05       Impact factor: 6.116

2.  Macrophage cathepsin K promotes prostate tumor progression in bone.

Authors:  M K Herroon; E Rajagurubandara; D L Rudy; A Chalasani; A L Hardaway; I Podgorski
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

3.  Identification of miR-708-5p in peripheral blood monocytes: Potential marker for postmenopausal osteoporosis in Mexican-Mestizo population.

Authors:  Aldo H De-La-Cruz-Montoya; Eric G Ramírez-Salazar; Mayeli M Martínez-Aguilar; Pablo M González-de-la-Rosa; Manuel Quiterio; Cei Abreu-Goodger; Jorge Salmerón; Rafael Velázquez-Cruz
Journal:  Exp Biol Med (Maywood)       Date:  2018-10-15

Review 4.  Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts.

Authors:  Brendan F Boyce
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

5.  Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data.

Authors:  Brendan Boyce; Lianping Xing
Journal:  Clin Investig (Lond)       Date:  2011-12-01

6.  The effect of fresh bone marrow cells on reconstruction of mouse calvarial defect combined with calvarial osteoprogenitor cells and collagen-apatite scaffold.

Authors:  Xiaohua Yu; Liping Wang; Fei Peng; Xi Jiang; Zengmin Xia; Jianping Huang; David Rowe; Mei Wei
Journal:  J Tissue Eng Regen Med       Date:  2012-03-31       Impact factor: 3.963

7.  Bone Physiology, Biomaterial and the Effect of Mechanical/Physical Microenvironment on MSC Osteogenesis: A Tribute to Shu Chien's 80th Birthday.

Authors:  Xiaoling Liao; Shaoying Lu; Yue Zhuo; Christina Winter; Wenfeng Xu; Bo Li; Yingxiao Wang
Journal:  Cell Mol Bioeng       Date:  2011-12       Impact factor: 2.321

8.  Interaction of Brucella abortus with Osteoclasts: a Step toward Understanding Osteoarticular Brucellosis and Vaccine Safety.

Authors:  Omar H Khalaf; Sankar P Chaki; Daniel G Garcia-Gonzalez; Larry J Suva; Dana Gaddy; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

9.  Taxonomy of rare genetic metabolic bone disorders.

Authors:  L Masi; D Agnusdei; J Bilezikian; D Chappard; R Chapurlat; L Cianferotti; J-P Devolgelaer; A El Maghraoui; S Ferrari; M K Javaid; J-M Kaufman; U A Liberman; G Lyritis; P Miller; N Napoli; E Roldan; S Papapoulos; N B Watts; M L Brandi
Journal:  Osteoporos Int       Date:  2015-06-13       Impact factor: 4.507

Review 10.  Advances in the regulation of osteoclasts and osteoclast functions.

Authors:  B F Boyce
Journal:  J Dent Res       Date:  2013-08-01       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.